146 related articles for article (PubMed ID: 27672505)
1. Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins.
Abdullah MI; Lee CC; Mat Junit S; Ng KL; Hashim OH
PeerJ; 2016; 4():e2450. PubMed ID: 27672505
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
[TBL] [Abstract][Full Text] [Related]
3. iTRAQ analysis of urinary proteins: Potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma.
Jayapalan JJ; Lee CS; Lee CC; Ng KL; Junit SM; Hashim OH
Clin Biochem; 2018 Mar; 53():127-131. PubMed ID: 29355489
[TBL] [Abstract][Full Text] [Related]
4. Decreased apolipoprotein A4 and increased complement component 3 as potential markers for papillary thyroid carcinoma: A proteomic study.
Farrokhi Yekta R; Arefi Oskouie A; Rezaei Tavirani M; Mohajeri-Tehrani MR; Soroush AR
Int J Biol Markers; 2018 Nov; 33(4):455-462. PubMed ID: 30058426
[TBL] [Abstract][Full Text] [Related]
5. Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas.
Paricharttanakul NM; Saharat K; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J
Oncol Rep; 2016 Apr; 35(4):2286-96. PubMed ID: 26782318
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1-antichymotrypsin immunoreactivity in papillary carcinoma of the thyroid gland.
Lai ML; Rizzo N; Liguori C; Zucca G; Faa G
Histopathology; 1998 Oct; 33(4):332-6. PubMed ID: 9822922
[TBL] [Abstract][Full Text] [Related]
7. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.
Wu CC; Lin JD; Chen JT; Chang CM; Weng HF; Hsueh C; Chien HP; Yu JS
Oncotarget; 2018 Feb; 9(15):12079-12100. PubMed ID: 29552294
[TBL] [Abstract][Full Text] [Related]
9. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses.
Graham ME; Hart RD; Douglas S; Makki FM; Pinto D; Butler AL; Bullock M; Rigby MH; Trites JR; Taylor SM; Singh R
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):33. PubMed ID: 26341226
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
[TBL] [Abstract][Full Text] [Related]
12. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
[TBL] [Abstract][Full Text] [Related]
13. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
[TBL] [Abstract][Full Text] [Related]
15. Serum miR-22 may be a biomarker for papillary thyroid cancer.
Wang D; Guo C; Kong T; Mi G; Li J; Sun Y
Oncol Lett; 2019 Mar; 17(3):3355-3361. PubMed ID: 30867770
[TBL] [Abstract][Full Text] [Related]
16. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
[TBL] [Abstract][Full Text] [Related]
17. Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer.
Liang Y; Ma T; Thakur A; Yu H; Gao L; Shi P; Li X; Ren H; Jia L; Zhang S; Li Z; Chen M
Glycobiology; 2015 Mar; 25(3):331-40. PubMed ID: 25347993
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
19. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
[TBL] [Abstract][Full Text] [Related]
20. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
